Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Morocco · Delayed Price · Currency is MAD

369.85

-0.15 (-0.04%)

At close: Aug 11, 2026

-0.04% (1Y)

Market Cap	14.17B +6.4%
Revenue (ttm)	3.23B +14.6%
Net Income	385.53M +22.3%
EPS	10.14 +15.7%
Shares Out	38.31M
PE Ratio	36.50
Forward PE	n/a
Dividend	6.60 (1.78%)
Ex-Dividend Date	Jul 1, 2026

Volume	142
Open	362.50
Previous Close	370.00
Day's Range	362.50 - 369.85
52-Week Range	304.00 - 395.00
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, antibiotic, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syru... [Read more]

Industry Pharmaceutical Preparations

Founded 1976

Employees 1,271

Stock Exchange Casablanca Stock Exchange

Ticker Symbol SOT

Full Company Profile

Financial Performance

In 2025, CBSE:SOT's revenue was 3.23 billion, an increase of 14.55% compared to the previous year's 2.82 billion. Earnings were 385.53 million, an increase of 22.28%.

Financial Statements